Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T07:43:30.913Z Has data issue: false hasContentIssue false
  • English
  • Français

A Possible Variant of the Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  02 January 2018

Caroline F. Sullivan
Caroline F. Sullivan*
Affiliation:
Liverpool Rotational Training Scheme
*
Address for correspondence Greaves Hall Hospital, Southport
Get access Rights & Permissions [Opens in a new window]

Abstract

A 20-year-old man developed generalised rigidity and signs of autonomic instability following the introduction of therapy with zuclopenthixol decanoate. A diagnosis of NMS was made, despite the absence of hyperthermia. He recovered on treatment with thiamine, dantrolene, and bromocriptine.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 151 , Issue 5 , November 1987 , pp. 689 - 690
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abbott, R. J. & Loizou, L. A. (1986) Neuroleptic malignant syndrome. British Journal of Psychiatry, 148, 47–51.Google Scholar
Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google Scholar
Coons, D. J., Hillman, F. J. & Marshall, R. W. (1982) Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report. American Journal of Psychiatry, 139, 944–945.Google ScholarPubMed
Gibb, W. R. G. & Lees, A. J. (1985) The neuroleptic malignant syndrome: a review. Quarterly Journal of Medicine, 56, 421–429.Google ScholarPubMed
Goulon, M., Rohan-Chabot, P., Elkharrat, D., Gajdas, P., Bismuth, G. & Cosmo, F. (1983) Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Neurology, 33, 516–518.Google Scholar
Price, W. A. & Giannini, A. J. (1983) A paradoxical response to chlorpromazine: a possible variant of the neuroleptic malignant syndrome. Journal of Clinical Pharmacology, 23, 567–569.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica, 73, 337–347.CrossRefGoogle ScholarPubMed
Shukla, S., Godwin, C. D., Long, L. E. B. & Miller, M. G. (1986) Lithium–carbamazepine neurotoxicity and risk factors. American Journal of Psychiatry, 141, 1604–1606.Google Scholar
Szabadi, E. (1984) Neuroleptic malignant syndrome (editorial). British Medical Journal, 288, 1399–1400.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.